In sum, our observations suggest that while not all APC mutant peptides are immunogenic, a library of empirically confirmed ones could qualify as vaccine candidates designed to target second hit somatic mutations in the APC gene that drive the formation of colon polyps. This evidence concerns the gene APC and polyp of colon.